Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears

Adenoviral Conjunctivitis Clinical Trial

Official title:
A Prospective Blinded Multi-center Clinical Trial to Evaluate the Efficacy of the Recently FDA Approved RPS Adeno Detector for Detecting Adenoviral Conjunctivitis

Status Completed

Clinical Trial Summary

To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00266734
Study type	Interventional
Source	Rapid Pathogen Screening
Contact
Status	Completed
Phase	N/A
Start date	December 2004
Completion date	September 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01532336` - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis	Phase 2
Terminated	`NCT02998554` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo	Phase 3
Terminated	`NCT02998541` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo	Phase 3
Completed	`NCT02472223` - Reducing Adenoviral Patient Infected Days	N/A
Terminated	`NCT00901693` - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis	Phase 2
Withdrawn	`NCT03009799` - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)	Phase 2
Active, not recruiting	`NCT03856645` - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Phase 2
Completed	`NCT03749317` - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis	Phase 2